Abstract WP311: Prevalence and In-Hospital Outcomes Associated with Cardiomyopathy Subtypes in Patients with Acute Ischemic Stroke
Stroke
Ischemic Cardiomyopathy
DOI:
10.1161/str.56.suppl_1.wp311
Publication Date:
2025-01-30T10:18:44Z
AUTHORS (10)
ABSTRACT
Introduction: Cardiomyopathy (CM) can occur in patients hospitalized with acute ischemic stroke (AIS). The epidemiology of AIS and concomitant CM subtypes is not well-described. Methods: Adult hospitalizations the National Inpatient Sample (NIS) from 2018-2020 diagnosis were characterized by etiologies using International Classification Diseases-10 codes. Demographic characteristics clinical outcome rates computed among each subtype. outcomes interest are detailed Table 1. Further statistical analyses within etiology subgroups performed given that encoded mutually exclusive. Results: Of 1,918,985 weighted hospitalizations, there 144,875 (7.6%) diagnosis, one-third due to two-thirds non-ischemic (CM exclusive, 1). Patients such as amyloid-induced older (mean ages 70.5 72.3 years, respectively) versus those peripartum sarcoidosis-related 33.5 48.5 respectively). There sex differences, more likely be male (71%) stress (24.9%). (72%) (68%) identified White, sarcoid-induced (88%) (54%) mostly Black. Intracardiac thrombus was detected decreasing order subtype: drug-induced (13.6%), alcohol-induced (7.7%), dilated (6.2%), restrictive (5.9%), (5.2%). Circulatory support most common (2.4% IABP). Thrombolysis use frequent (18%), (9.3%), (8.8%), (8.2%). EVT subtype were: Chagas-associated, wet Beriberi, sarcoidosis-induced CMs (88-100%), (10.1%), stress-induced (7.7%). Stress-induced associated highest in-hospital mortality rate (17%) lowest frequency routine discharge (18%). Conclusions: We describe AIS, cardiac stroke-related procedures these undergo, their outcomes. Understanding demographic specific may provide insight into multidisciplinary management this vulnerable population.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....